Scholarlink

Background <p>Menopausal symptoms after cancer (MSAC) are common and can affect overall quality of life. Cancer survivors experience a variety of symptoms for which they may seek support from healthcare professionals (HCPs). Yet, managing MSAC may be challenging for some HCPs. Therefore, understanding HCPs’ perspectives and challenges in providing MSAC care could help propose solutions to improve care provision.</p> Methods <p>Using semi-structured, one-on-one interviews, we explored the perspectives and challenges of 20 HCPs from a range of specialties involved in the care of women with MSAC. Interviews were transcribed and analyzed using a reflexive thematic approach with NVivo v12.</p> Results <p>Twenty HCPs aged 37–68&#xa0;years were interviewed. The sample comprised females (<i>n</i> = 17), with primary care physicians being the largest HCP grouping (<i>n</i> = 6), of whom half were MSAC specialists. Participants’ clinical experience ranged from 1 to 35&#xa0;years (19.95 ± 9.88), and their experience in managing MSACs ranged from 3 to 35&#xa0;years (14.25 ± 8.69). Five themes with 10 subthemes were identified: (1) contested view of menopause after cancer; (2) HCPs’ resilience in patient-centred care; (3) multidisciplinary patient care; (4) trial, adaptation, and the search for symptom relief; and (5) care constrained by uncertainty and risk.</p> Conclusion <p>HCPs recognized the substantial burden of MSAC and have adopted patient-centred care and multidisciplinary approaches. However, the confidence in prescribing menopausal hormone therapy was identified as an area for improvement in clinical practice. For all categories of HCPs, upskilling through targeted education and decision-support tools may improve care.</p> Implications for Cancer Survivors <p>For cancer survivors, these findings indicate that HCPs recognise the burden of menopausal symptoms after cancer and that improvements in clinician education, decision‑support tools and clearer referral pathways should translate into timelier, evidence‑informed care (including considered use of MHT where appropriate), better multidisciplinary support and shared decision‑making — all of which aim to reduce symptom burden and improve quality of life.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Managing menopause after cancer: a qualitative analysis of healthcare professionals’ perspectives

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月18日

查看全文
  • Dorcas Serwaa,
  • Shanton Chang,
  • Lewis Gauci,
  • Michael Jefford,
  • Carolyn Ee,
  • Martha Hickey,
  • Kate Rolshoven,
  • Jennifer L. Marino,
  • Paul A. Cohen,
  • Christobel Saunders,
  • Nipuni Susanto,
  • Michelle Peate

摘要

Background

Menopausal symptoms after cancer (MSAC) are common and can affect overall quality of life. Cancer survivors experience a variety of symptoms for which they may seek support from healthcare professionals (HCPs). Yet, managing MSAC may be challenging for some HCPs. Therefore, understanding HCPs’ perspectives and challenges in providing MSAC care could help propose solutions to improve care provision.

Methods

Using semi-structured, one-on-one interviews, we explored the perspectives and challenges of 20 HCPs from a range of specialties involved in the care of women with MSAC. Interviews were transcribed and analyzed using a reflexive thematic approach with NVivo v12.

Results

Twenty HCPs aged 37–68 years were interviewed. The sample comprised females (n = 17), with primary care physicians being the largest HCP grouping (n = 6), of whom half were MSAC specialists. Participants’ clinical experience ranged from 1 to 35 years (19.95 ± 9.88), and their experience in managing MSACs ranged from 3 to 35 years (14.25 ± 8.69). Five themes with 10 subthemes were identified: (1) contested view of menopause after cancer; (2) HCPs’ resilience in patient-centred care; (3) multidisciplinary patient care; (4) trial, adaptation, and the search for symptom relief; and (5) care constrained by uncertainty and risk.

Conclusion

HCPs recognized the substantial burden of MSAC and have adopted patient-centred care and multidisciplinary approaches. However, the confidence in prescribing menopausal hormone therapy was identified as an area for improvement in clinical practice. For all categories of HCPs, upskilling through targeted education and decision-support tools may improve care.

Implications for Cancer Survivors

For cancer survivors, these findings indicate that HCPs recognise the burden of menopausal symptoms after cancer and that improvements in clinician education, decision‑support tools and clearer referral pathways should translate into timelier, evidence‑informed care (including considered use of MHT where appropriate), better multidisciplinary support and shared decision‑making — all of which aim to reduce symptom burden and improve quality of life.